Metraipolis › archive › dc_590dd84497cb

Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation — Europe PMC PMID:42164241

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164241
DOI
10.1016/j.omta.2026.201742
License (as archived)
solo-consultazione
Archived
2026-10-08T02:33:02.700Z
SHA-256 of the archived text
ce971a650664650c11798ba00b39c189b438a03b04b12687e28df67e8d334450
Stable URL of this page
https://metraipolis.com/documento/dc_590dd84497cb

How to cite

Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation — Europe PMC PMID:42164241 — Europe PMC (en), https://europepmc.org/article/MED/42164241 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_590dd84497cb (Metraipolis archive dc_590dd84497cb, sha256 ce971a650664650c11798ba00b39c189b438a03b04b12687e28df67e8d334450)
BibTeX
@misc{dc590dd84497cb,
  title = {Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation — Europe PMC PMID:42164241},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164241},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_590dd84497cb; sha256 ce971a650664650c11798ba00b39c189b438a03b04b12687e28df67e8d334450},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164241. Agents can read the archived copy with the MCP tool read_document.